Number of the records: 1  

Comparison of the pharmacological and biological properties of HPMA copolymer-pirarubicin conjugates: A single-chain copolymer conjugate and its biodegradable tandem-diblock copolymer conjugate

  1. 1.
    SYSNO ASEP0475079
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleComparison of the pharmacological and biological properties of HPMA copolymer-pirarubicin conjugates: A single-chain copolymer conjugate and its biodegradable tandem-diblock copolymer conjugate
    Author(s) Etrych, Tomáš (UMCH-V) RID, ORCID
    Tsukigawa, K. (JP)
    Nakamura, H. (JP)
    Chytil, Petr (UMCH-V) RID, ORCID
    Fang, J. (JP)
    Ulbrich, Karel (UMCH-V) RID
    Otagiri, M. (JP)
    Maeda, H. (JP)
    Source TitleEuropean Journal of Pharmaceutical Sciences. - : Elsevier - ISSN 0928-0987
    Roč. 106, 30 August (2017), s. 10-19
    Number of pages10 s.
    Languageeng - English
    CountryNL - Netherlands
    Keywordspirarubicin ; PHPMA conjugate ; tandem-diblock PHPMA conjugate
    Subject RIVFR - Pharmacology ; Medidal Chemistry
    OECD categoryPharmacology and pharmacy
    R&D ProjectsGA15-02986S GA ČR - Czech Science Foundation (CSF)
    LQ1604 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    ED1.1.00/02.0109 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Institutional supportUMCH-V - RVO:61389013
    UT WOS000406988600002
    EID SCOPUS85019559040
    DOI10.1016/j.ejps.2017.05.031
    AnnotationIn this study, we compared the enhanced permeability and retention (EPR) effect, toxicity, and therapeutic effect of the conjugate of the linear polymer poly(N-(2-hydroxypropyl)methacrylamide) (HPMA) with pirarubicin with an Mw below the renal threshold (39 g/mol) (named LINEAR) and the disulfide-linked tandem-polymeric dimer of the poly(HPMA)-pirarubicin conjugate with an Mw above the renal threshold (93 g/mol) (named DIBLOCK). The DIBLOCK conjugate, which was susceptible to reductive degradation, showed both a better EPR effect (tumor delivery) (2.5 times greater at 24 h) and a prolonged plasma half-life. In addition, DIBLOCK had a better antitumor effect, as judged by percent survival, than did LINEAR (80% vs 65% at 150 days), without any apparent toxicity in an S180 tumor model. However, the LD50 value of LINEAR was slightly higher than that of DIBLOCK (50 mg/kg vs 37.5 mg/kg, respectively). DIBLOCK required a longer time than LINEAR to reach maximum accumulation in the tumor. DIBLOCK also showed a greater time-dependent increase in the concentration in the tumor compared with the plasma concentration.
    WorkplaceInstitute of Macromolecular Chemistry
    ContactEva Čechová, cechova@imc.cas.cz ; Tel.: 296 809 358
    Year of Publishing2018
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.